文献速递慢阻肺哮喘

中东欧吸烟史COPD患者表型:POPE研究

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study.
PubMed 文献 · Eur Respir J · 2017-05-11

POPE研究纳入10个中东欧国家3362例稳定期COPD患者,按预设标准评估表型分布。结果显示63%为非频繁急性加重者,20.4%为频繁急性加重伴慢性支气管炎,9.5%为频繁急性加重不伴慢性支气管炎,6.9%为哮喘-COPD重叠。各表型在症状负荷、肺功能、合并症和治疗上存在显著差异。

要点

  • 中东欧稳定期COPD患者以非频繁急性加重表型为主(63%)。
  • 哮喘-COPD重叠表型占6.9%,各国表型分布存在差异。
  • 不同表型在症状负荷、肺功能、合并症和治疗上差异显著。

核心结论

  • 中东欧稳定期COPD患者以非频繁急性加重者为主,但预设表型间在疾病严重程度替代指标和治疗上存在明显差异。

研究设计与样本

  • POPE研究为在10个中东欧国家真实世界环境中招募稳定期COPD患者的观察性研究,共纳入3362例患者。
  • 主要目标是按预设标准评估表型患病率,次要目标包括分析症状负荷、合并症和药物治疗差异。

主要发现

  • 63%的患者为非频繁急性加重者,20.4%为频繁急性加重伴慢性支气管炎,9.5%为频繁急性加重不伴慢性支气管炎,6.9%为哮喘-COPD重叠。
  • 各国间表型分布存在差异,非频繁急性加重队列异质性最高,哮喘-COPD队列异质性最低。
  • 各表型间症状负荷、肺功能、合并症和治疗存在统计学显著差异。

临床怎么用

  • 中东欧稳定期COPD患者多数为非频繁急性加重者,临床评估需结合表型区分症状负荷、合并症和治疗需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients in this region.Participation in the Phenotypes of COPD in Central and Eastern Europe (POPE) study was offered to stable patients with COPD in a real-life setting. The primary aim of this study was to assess the prevalence of phenotypes according to predefined criteria. Secondary aims included analysis of differences in symptom load, comorbidities and pharmacological treatment.3362 patients with COPD were recruited in 10 CEE countries. 63% of the population were nonexacerbators, 20.4% frequent exacerbators with chronic bronchitis, 9.5% frequent exacerbators without chronic bronchitis and 6.9% were classified as asthma-COPD overlap. Differences in the distribution of phenotypes between countries were observed, with the highest heterogeneity observed in the nonexacerbator cohort and the lowest heterogeneity observed in the asthma-COPD cohort. There were statistically significant differences in symptom load, lung function, comorbidities and treatment between these phenotypes.The majority of patients with stable COPD in CEE are nonexacerbators; however, there are distinct differences in surrogates of disease severity and therapy between predefined COPD phenotypes.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Koblizek V, Milenkovic B, Barczyk A, et al. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study. Eur Respir J. 2017. PMID: 28495687. doi:10.1183/13993003.01446-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。